S. 5237 — Stop Superbugs Act

This section directs the Director of the National Institute of Allergy and Infectious Diseases to award a competitive grant to the Antibiotic Resistance Leadership Group to operate a clinical research network on antibiotic resistance. The network must support rapid trial participant recruitment, community outreach for recruitment, pairing of diagnostic and pharmaceutical innovations in trials, and development of patient-reported outcomes. It authorizes such sums as may be necessary.